In tendinitis, as a very common and painful condition disabling musculoskeletal functionality and still lacking sustainable treatment, various plant-derived compounds have been demonstrated to affect inflammation and promote tissue healing, thus representing promising bio-active treatment agents in tendinitis therapy.
Agent | Origin | Type of Trial | Presumed Modulation | Mode of Action | Concentration/Dose Range | Reference |
---|---|---|---|---|---|---|
Avocado/Soybean unsaponifiables (ASU) | avocado and soybean oils | in vitro, horse tenocytes |
IL-1β COX-2 PGE2 |
Avocado/soybean unsaponifiables significantly inhibited inflammation response, such as combination therapy with glucosamine and chondroitin sulfate. | 8.3 μg/mL of ASU | [157] |
Boswellia acid | Boswellia serrata | in vivo, Achilles tendinitis patients |
- | Boswellia acid (as Casperome®) showed pain reduction on a visual analogical scale when Casperome® was administered in addition to physical therapy in patients with Achilles tendinitis. | 250 mg of Casperome® for 15 and 30 days | [210] |
in vivo, joint inflammation patients |
- | Boswellia acid (as Casperome®) supplementation accompanied by standard therapy reduced pain and inflammation in knee joints and tendon of rugby players. | 500 mg of Casperome® for 5 days, then 250 mg for 23 days | [211] | ||
in vivo, supraspinatus injury patients |
- | Boswellia serrata and Curcuma longa extracts (as Tendisulfur®) reduced pain after arthroscopic supraspinatus tendon repair compared to placebo treatment. | 2 daily sachets Tendisulfur® for 15 days, then 1 daily sachet for 45 days | [212] | ||
in vivo, tendinopathy patients |
- | Boswellia serrata and Curcuma longa extracts alleviated the symptoms (pain and functional limitation) of patients with tendon disease when applied as combinational therapy. | 2 tablets twice a day for 1 month | [65] | ||
in vivo, rotator cuff tendinopathy, Achilles tendinopathy, and lateral epicondylitis patients |
- | Boswellia serrata, Curcuma longa and bromelain extracts (with methyl-sulfonyl-methane, hydrolysed collagen I and II, L-arginine, L-lysin, vitamin C, chondroitin sulfate, glucosamine, and myrrh as Tendisulfur® Forte), in combination with extracorporeal shock wave therapy, accelerated pain relief and remarkably reduced NSAID intake of patients. | 2 daily tablets of Tendisulfur® Forte for 1 month, then once a day for a month | [213] | ||
Bromelain | pineapple extracts, Ananas cosmosus | in vivo, Sprague–Dawley rats |
MDA ROS |
Pineapple flesh extract stimulated tenoblast proliferation and thus tendon healing after Achilles tendon injury. | 30 mg/kg of pineapple flesh axtract for 14 days | [161] |
in vivo, Sprague–Dawley rats |
ROS PAF |
Pineapple extract bromelain shifted the thromboxane–prostacyclin ratio towards prostacyclin and increased the tenocyte population after Achilles tendon injury. | 7 mg/kg of bromelain for 14 days | [130,163] | ||
in vivo, Achilles tendinopathy patients |
- | Pineapple extract bromelain (as dietary supplement Tenosan with arginine, collagen, vitamin C, methyl-sulfonyl-methane, VinitroxTM) boosted the efficacy of extracorporeal shock wave therapy, resulting in better functional and clinical outcome, compared to placebo treatment. | 2 daily drug sachets containing 50 mg of bromelain for 60 days | [214] | ||
in vivo, rotator cuff tendinopathy patients |
- | Pineapple extract bromelain (as dietary supplement Tenosan with arginine L-alpha-ketoglutarate, methyl-sulfonyl-methane and hydrolysed collagen I) reduced pain and improved repair integrity of rotator cuff repair. | 2 daily drug sachets containing 50 mg of bromelain for 3 months | [215] | ||
in vivo, rotator cuff tendinopathy, Achilles tendinopathy, and lateral epicondylitis patients |
- | Pineapple extract bromelain (with methyl-sulfonyl-methane, hydrolysed collagen I and II, L-arginine, L-lysin, vitamin C, chondroitin sulfate, glucosamine, Curcuma longa, Boswellia serrata, and myrrh as Tendisulfur® Forte), in combination with extracorporeal shock wave therapy, accelerated pain relief and remarkably reduced NSAID intake of patients. | 2 daily tablets of Tendisulfur® Forte for 1 month, then once a day for an additional month | [213] | ||
Curcuminoids | turmeric, Curcuma longa | in vitro, canine tenocytes |
NF-κB scleraxis TNF-α TNF-β |
Calebin A suppressed inflammation and exhibited potential as preventive and therapeutic treatment of tendinitis by suppressing down-regulation of tenomodulin and collagen I. | 1–10 µM of calebin A | [36] |
in vitro, human tenocytes |
NF-κB IL-1βPI3K/p85/Akt MMPs COX-2 caspase-3 Bax/Bcl-2 |
Curcumin inhibited inflammation and apoptosis and showed potential for treatment of tendon inflammation. | 5 µM of curcumin | [10] | ||
in vivo, diabetic rats |
ROS AGE |
Curcumin reduced oxidative stress by inhibiting lipid peroxidation and prevented glycation and crosslinking of advanced glycated collagen in tail tendon and skin. | 200 mg/kg of curcumin for 8 weeks | [168] | ||
in vivo, Sprague–Dawley rats |
MDA HOPro SOD |
Curcumin improved the healing quality of tendon ruptures by promoting well-organized collagen filaments and biomechanical traits. | 100 mg/kg of curcumin for 14 days | [64] | ||
in vivo, Sprague–Dawley rats |
adhesion of inflammatory products | Curcumin (as loaded nanoparticle) promoted the healing process of Achilles tendon rupture. | 1 injection containing 0.44 mg of curcumin/kg | [169] | ||
in vivo, Wistar albino rats |
- | Curcumin showed biomechanical and histological healing (collagen I and III) promotion after surgically treated Achilles tendon ruptures. | 200 mg/kg of curcumin for 28 days | [170] | ||
in vivo, rats |
AP | Curcumin prevented tendon calcification and improved tendon regeneration by tendon stem/progenitor cells. | 3 μg of curcumin every 3 days for up to 4 weeks | [131] | ||
in vivo, Sprague–Dawley rats |
ROS IL-1β TNF-α MMPs |
Curcumin showed anti-oxidative and anti-inflammatory properties as part of Cur&Mg-QCS/PF hydrogel application. | 1 injection with 50 µL of hydrogel | [146] | ||
in vivo, diabetic rats |
AGE HOPro |
Curcumin’s metabolite tetrahydrocurcumin reduced accumulation and crosslinking of advanced glycated collagen. | 80 mg/kg of tetrahydrocurcumin for 45 days | [172] | ||
in vivo, tendinopathy patients |
- | Curcuma longa and Boswellia serrata extracts alleviated the symptoms (pain and functional limitation) of patients with tendon disease as combinational therapy. | 2 tablets twice a day for 1 month | [65] | ||
in vivo, rotator cuff tendinopathy, Achilles tendinopathy, and lateral epicondylitis patients |
- | Curcuma longa, Boswellia serrata and bromelain extracts (with methyl-sulfonyl-methane, hydrolysed collagen I and II, L-arginine, L-lysin, vitamin C, chondroitin sulfate, glucosamine, and myrrh as Tendisulfur® Forte), in combination with extracorporeal shock wave therapy, accelerated pain relief and remarkably reduced NSAID intake of patients. | 2 daily tablets of Tendisulfur® Forte for 1 month, then once a day for an additional month | [213] | ||
in vivo, supraspinatus injury patients |
- | Curcuma longa and Boswellia serrata extracts (as Tendisulfur®) reduced pain after arthroscopic supraspinatus tendon repair compared to placebo treatment. | 2 daily sachets of Tendisulfur® for 15 days and 1 daily sachet for the next 45 days | [212] | ||
EGCG (epigallocatechin gallate) | green tea extracts | in vitro, human tendon-derived fibroblasts |
IL-1β MMPs p54/JNK/ SAPK collagenases/ gelatinases/ aggrecanases |
Green tea’s epigallocatechin gallate targeted extracellular matrix breakdown. | 2.5–25 µM of epigallocatechin gallate | [148] |
in vivo, diabetic rats |
AGE | Green tea extract reduced collagen glycation and crosslinking in the tail tendon. | 300 mg/kg of green tea extract for 4 weeks | [145] | ||
in vivo, Wistar rats |
MMPs HOPro |
Green tea promoted the synthesis of ECM components and glycosaminoglycans, and thus the recovery process after Achilles tendinitis in combination with a glycin diet. | 700 mg/kg of green tea extract for 21 days | [177] | ||
in vivo, Wistar rats |
IL-1β MMPs |
Green tea modulated inflammatory action and promoted synthesis of recovery elements after Achilles tendinitis, in combination with a glycin diet. | 700 mg/kg of green tea extract for 7 days | [132] | ||
in vivo, C57BL/6 mice |
ROS | Green tea extract slowed collagen aging by inhibiting crosslinking. | 21.2 mL (young mice) and 27.2 mL (adult mice) of green tea extract for 14 days | [176] | ||
Echinaceae angustifolia extracts | Echinaceae angustifolia | in vivo, carpal tunnel syndrome patients |
- | Echinaceae angustifolia extract (as a dietary supplement mainly composed of alpha lipoic acid and conjugated linoleic acid) showed significant improvement in pain, symptoms, and functionality. | 2 capsules containing 250 mg of echinacea extract for 40 days, then 1 capsule for 80 days | [216] |
Flavones/Flavonoids | celery, parsley, red peppers, chamomile, mint and gingko bilboa, citrus fruit |
in vitro, rat tenofibroblast |
ROS ERK1/2 JNK |
Flavonoid anthocyanin acted as an anti-apoptotic and showed the therapeutic potential of rotator cuff tendon. | 10–200 µg/mL of anthocyanins | [133] |
in vitro, tendon stem cells |
caspase-3 | Flavonoid eriocitrin inhibited apoptosis and scar formation (biglycan, fibronectin, COMP) and improved woundhealing by stimulating proliferation and migration of tendon stem cells. | 25–75 of µM eriocitrin | [147] | ||
in vivo, Sprague–Dawley rats |
- | Flavone genistein protected ovariectomy-induced collagen reduction in Achilles tendon. | 300 mg/kgof genistein for 6 weeks | [184] | ||
in vivo, Sprague–Dawley rats |
Pcna Timp1 |
Flavone genistein enhanced tendon function at an estrogen-deficit through the modulation of tenomodulin. | 6 mg/kg of genistein for 6 weeks | [185] | ||
in vivo, Sprague–Dawley rats |
AP CD31 VEGF |
Flavonoid icariin supported healing and angiogenesis after rotator cuff reconstruction through promoting collagen I/II. | 0.125 mg/g of icariin for 2 and 4 weeks | [189] | ||
in vivo, Wistar rats |
ROS MDA SOD GPX |
Flavonoid quercetin prevented the adhesion of tendon tissue. | 50–100 mg/kg for 4 weeks | [195] | ||
in vivo, Sprague–Dawley rats |
MMPs ICAM-1 |
Flavonoid quercetin prevented collagenase-induced tendon damage at Achilles tendinopathy. | 25–50 mg/kg for 7 days | [149] | ||
in vivo, rats |
- | Flavonoid quercetin, kaempferol, and isorhamnetin (Hippophae rhamnoides’ flavones) improved fibre alignment, collagen deposition, healing, and recovery after patellar tendon injury. | 1 injection with 0.1 mg of Hippophae rhamnoides’ flavones | [144] | ||
Resveratrol | red grapes, Vitis vinifera |
in vitro, human tenocytes |
NF-κB p53 Sirt-1 IL-1β COX-2 MMPs Akt/scleraxis Bax/caspase-3 |
Resveratrol regulated tenocytes homeostatic and inhibited inflammation of cascades and apoptosis. | 5 µM of resveratrol | [62] |
in vitro, human tenocytes |
Sirt-1 | Resveratrol averted dexamethasone-induced senescence despite glucocorticoid treatment. | 30 µM of resveratrol | [207] | ||
in vitro, human tenocytes |
NF-κB PI3K IL-1β scleraxis |
Resveratrol inhibited inflammation cascades; prevented apoptosis; and promoted collagen I, collagen III, and tenomodulin expression. | 0.1–20 µM of resveratrol | [14] | ||
in vitro, Wistar rat tail tendon |
ROS | Resveratrol’s derivate polydatin protected from advanced glycation as an anti-oxidant property. | 50–500 µg of polydatin | [209] | ||
in vivo, Sprague–Dawley rats |
- | Resveratrol promoted the collagens and the healing process of Achilles tendinopathy, despite diabetic condition. | 10 mg/kg of resveratrol for 14 days | [61] |
This entry is adapted from the peer-reviewed paper 10.3390/nu14102030